Portrait of Nancy Ann Oberheim Bush
ucsf logo

Nancy Ann Oberheim Bush, MD, PhD

Neuro-Oncology
Neuro-Oncology Parnassus
415-353-7500
Portrait of Nancy Ann Oberheim Bush
Portrait of Nancy Ann Oberheim Bush
ucsf logo

Nancy Ann Oberheim Bush, MD, PhD

Neuro-Oncology
Neuro-Oncology Parnassus
415-353-7500

On this page

Education & training

Board certification

  • Neurology, American Board of Psychiatry and Neurology

Fellowship

  • Neuro-Oncology, University of CA at San Francisco - Urology GME

Residency

  • Neurology, UCSF School of Medicine -GME

Internship

  • Neurology, UCSF School of Medicine -GME

Degree

  • MD, University of Rochester School of Medicine

Academic title

  • Clinical Professor

My expertise

Locations

    My research

    Reviews

    Average rating

    4.9
    4.9 out of 5 Stars
    330 ratings
    About provider reviews

    Showing 1-6 of 94 reviews

    Sort by
    • 5 out of 5 Stars
      August 28, 2026

      This provider is always very thorough, friendly, caring, and informed.

    • 5 out of 5 Stars
      August 26, 2026

      Dr. Bush is great.

    • 5 out of 5 Stars
      August 23, 2026

      Dr. Nancy Ann Oberheim Bush is a kind and caring person. I love her knowledge about my astrocytoma and how to move forward.

    • 5 out of 5 Stars
      August 23, 2026

      Very good

    • 4.8 out of 5 Stars
      July 30, 2026

      Dr. Nancy O Bush listened carefully, carefully answered my questions, and made me feel comfortable. She's a great communicator.

    • 5 out of 5 Stars
      July 28, 2026

      Very professional and caring

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

    The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.